Bu dergideki yayınlar

1 →
  • Review ArticleYayıncıda açık erişim2026
    High Tibial Osteotomy (HTO) Versus Unicompartmental Knee Arthroplasty (UKA) in Medial-Compartment Knee Osteoarthritis (KOA): A Critical Narrative Review of Comparative Costs and Cost-Effectiveness

    Yapıcı, Furkan

    Background: Medial-compartment knee osteoarthritis (KOA) carries substantial disability and long-term cost. High tibial osteotomy (HTO) and unicompartmental knee arthroplasty (UKA) are key joint-preserving or joint-replacing options for selected patients, but their comparative economic ranking remains uncertain. Methods: This critical narrative review synthesized comparative economic evidence on HTO versus UKA for isolated medial-compartment KOA. PubMed and Web of Science were searched as primary sources for English-language studies published from 1 January 2000 to 15 January 2026, while Google Scholar and citation tracking were used supplementarily to identify potentially missed records. Eligible studies were direct economic evaluations or comparative cost/resource studies with clear decision relevance to the HTO–UKA choice. Burden and cost-of-illness studies were used for contextual framing only and were not included in the core comparative synthesis. Results: The direct evidence base was small and methodologically heterogeneous and was dominated by decision-analytic models that differed in perspective, time horizon, utility metric, and assumptions regarding reoperation, revision, and conversion to total knee arthroplasty (TKA). These structural differences largely explain why a U.S. lifetime societal model favored HTO, a UK age-stratified 10-year model produced age-dependent findings, and a recent Canadian public-payer model favored UKA. Observational studies suggest that UKA episode costs can fall substantially in outpatient or ambulatory pathways, whereas HTO costs may rise when reoperations and technique-specific resource use are explicitly captured. Conclusions: Current evidence does not support a context-free economic ranking of HTO and UKA. Because the available studies are heterogeneous and incremental utility differences are often small, the findings should be interpreted cautiously and as scenario-dependent rather than definitive. Future comparative analyses should use contemporary pathway data, transparent and standardized costing, and explicit downstream event definitions for both procedures.

    RDL Kalıcı Kaydıİncele
Tam Kayıt
AlanDeğerDil
creativeworkseries.issn2813-0618
dc.date.accessioned2026-10-20T15:33:11.961337799Z
dc.date.available2026-10-20T15:33:11.961337799Z
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/23261
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titlePharmacoepidemiology
dspace.entity.typeJournal